Brigimadlin, also known as BI-907828, is an E3 ubiquitin-protein ligase Mdm2 inhibitor with potential as an antineoplastic agent.BI-907828 is a novel potent MDM2 inhibitor. BI-907828 inhibits GBM brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models. BI-907828 decreases viability and induces cell death at picomolar concentrations, in both MDM2 amplified and normal copy number, TP53 wild-type BTSC lines. BI-907828 provides a promising new therapeutic option for patients with TP53 wild-type primary brain tumors.
MedKoo Cat#: 130021
Name: Brigimadlin free base
CAS#: 2095116-40-6 (free base)
Chemical Formula: C31H25Cl2FN4O3
Exact Mass: 590.1288
Molecular Weight: 591.46
Elemental Analysis: C, 62.95; H, 4.26; Cl, 11.99; F, 3.21; N, 9.47; O, 8.11
The following data is based on the product molecular weight 591.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |